In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

The current prior authorization process in U.S. healthcare constitutes a crisis, according to Jesse Ehrenfeld, immediate past ...

Healthcare and benefits leaders must step up to provide menopausal women with the full-spectrum care they need to protect ...

Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never ...

WeightWatchers recently filed for bankruptcy. Part of the reason is because it couldn't adapt fast enough to a rapidly ...

Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor and ...

President Trump’s latest strategy to tackle high drug prices aims to tie the price of U.S. prescription medicines to the prices paid for the same products in other countries, a so-called “most ...

The law that created ASTP as a formal federal agency gave it duties such as supporting a more effective marketplace and greater competition. Stephen Konya, ASTP’s chief, innovation and strategic ...

GSK is expanding its prospects in hepatology, paying $1.2 billion to acquire a drug that goes after a clinically validated liver target but with a dosing advantage that could give it a competitive ...

Threat actors continue to refine their strategies, and the financial incentives for cybercrime persist. However, the combination of stronger defenses, regulatory pressure, and industry collaboration ...

After years of limited activity, the digital health sector is finally showing signs of life in the public markets. Only a few companies have filed to go public in recent years, including Waystar ...

Every minute matters in healthcare. Outdated systems and disjointed workflows can stall the flow of critical clinical information. Today’s providers often face the challenge of retrieving vital ...